Center for Cognitive Health https://validator.w3.org/feed/docs/rss2.html ONO-2020: Can Epigenetics be a New Path in Alzheimer’s Disease Research? Clinical Trials Our Clinic TREM2, Microglia, and Alzheimer’s: The Final Puzzle Piece? Home Xanamem: Targeting Cortisol to Combat Cognitive Decline Testimonials Frequently Asked Questions Resources Free Memory Screens Our Team Blog Insulin Resistance and Alzheimer’s: A Two Way Street (and How GLP-1 Receptor Agonists May Help Cross It) Introduction to Neuroinflammation Lithium Deficiency and its possible role in Cognitive Decline Targeting Epigenetic Mechanisms in Alzheimer’s Disease Biomarker Assessments: The Future of Alzheimer’s Diagnosis Comparing Prodromal Dementia with Lewy Bodies, Prodromal Alzheimer’s Disease, and Parkinson’s Disease Could Non-Optimal Sleeping Patterns Predict Cognitive Decline and Change in Brain Structure? Caregiver Well-Being and Resources Gene Expression and Resilience Against Alzheimer’s Disease Pathology Normal Aging vs. Early Alzheimer’s Disease The Case for the Amyloid Hypothesis Donanemab Research Links Amyloid and p-tau217 The Interplay Between Alzheimer’s Disease Biomarkers and Predicting Cognitive Decline Understanding Why Tangles Spread in Alzheimer’s Disease: Part I Understanding Why Tangles Spread in Alzheimer’s Disease: Part II Tau: How Different Isoforms Predict Different Stages of AD Progression Exercise Related Neuroinflammatory Factor: Isolated Rationale for Amyloid-Beta Targeting Therapies for Early AD Treatment Diagnostic Testing for Alzheimer’s Disease: Are Blood Tests an Upcoming Promise? Psychedelics May Help Treat Neurodegenerative Disorders Hope on the Horizon: Breakthrough Investigational Treatments for Neurodegenerative Diseases Lion’s Mane: A Mushroom to Remember Donanemab: A Promising Anti-Amyloid Therapy Parkinson’s Disease and Dementia with Lewy Bodies: Could Molecule ATH-1017 Show Efficacy for Treatment of Each? Why has Biogen’s aducanumab become so controversial? Donanemab and the Future of Alzheimer’s Disease Treatment Welcome! Our Research How to Lower Your Risk for Alzheimer’s Disease Amyloid PET Identifies Those At Risk For Alzheimer’s Disease The Curious Case of Alzheimer’s-Related Primary Progressive Aphasia How PWAS Helped Discover 10 New Alzheimer’s Genes FDA Cites 17 Companies For Illegally Marketing Dietary Supplements as Treatments For Dementia Looking At The Use Of L-serine and Potential Health Benefits/Risks Acti-v8 Your Brain Hobbies, Are They Really That Important? IDEAS Study Results Tips and Resources For Caregivers